Skip to content

Agilent Technologies A Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Revvity logo
RevvityRVTY
Danaher logo
DanaherDHR
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
Bruker logo
BrukerBRKR
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
AVT
AvantorAVTR

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$37.52B+8.8%
Enterprise value$39.25B+7.0%
P/E26.5×-3.0×
P/S5.2×0.0×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's common stock, shares, outstanding?
Agilent Technologies (A) reported common stock, shares, outstanding of $282.22M in Q1 2026.
How has Agilent Technologies's common stock, shares, outstanding changed year-over-year?
Agilent Technologies's common stock, shares, outstanding decreased by 0.6% year-over-year, from $283.94M to $282.22M.
What is the long-term trend for Agilent Technologies's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Agilent Technologies's common stock, shares, outstanding has grown at a -1.5% compound annual growth rate (CAGR), from $306M to $283.05M.